annual total liabilities:
$160.96M+$46.15M(+40.20%)Summary
- As of today (May 21, 2025), CORT annual total liabilities is $160.96 million, with the most recent change of +$46.15 million (+40.20%) on December 31, 2024.
- During the last 3 years, CORT annual total liabilities has risen by +$113.01 million (+235.69%).
- CORT annual total liabilities is now at all-time high.
Performance
CORT Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$163.17M+$2.21M(+1.37%)Summary
- As of today (May 21, 2025), CORT quarterly total liabilities is $163.17 million, with the most recent change of +$2.21 million (+1.37%) on March 31, 2025.
- Over the past year, CORT quarterly total liabilities has increased by +$55.10 million (+50.98%).
- CORT quarterly total liabilities is now at all-time high.
Performance
CORT quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CORT Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.2% | +51.0% |
| 3 y3 years | +235.7% | +170.5% |
| 5 y5 years | +291.4% | +353.2% |
CORT Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +235.7% | at high | +201.9% |
| 5 y | 5-year | at high | +291.4% | at high | +353.2% |
| alltime | all time | at high | +8724.8% | at high | >+9999.0% |
CORT Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $163.17M(+1.4%) |
| Dec 2024 | $160.96M(+40.2%) | $160.96M(+10.7%) |
| Sep 2024 | - | $145.42M(+22.9%) |
| Jun 2024 | - | $118.31M(+9.5%) |
| Mar 2024 | - | $108.07M(-5.9%) |
| Dec 2023 | $114.81M(+40.7%) | $114.81M(-13.2%) |
| Sep 2023 | - | $132.34M(+28.5%) |
| Jun 2023 | - | $103.01M(+16.7%) |
| Mar 2023 | - | $88.26M(+8.2%) |
| Dec 2022 | $81.59M(+70.2%) | $81.59M(+36.2%) |
| Sep 2022 | - | $59.89M(+10.8%) |
| Jun 2022 | - | $54.04M(-10.4%) |
| Mar 2022 | - | $60.31M(+25.8%) |
| Dec 2021 | $47.95M(-0.9%) | $47.95M(+6.2%) |
| Sep 2021 | - | $45.17M(-1.4%) |
| Jun 2021 | - | $45.80M(+10.1%) |
| Mar 2021 | - | $41.60M(-14.0%) |
| Dec 2020 | $48.39M(+17.7%) | $48.39M(+8.9%) |
| Sep 2020 | - | $44.45M(+0.7%) |
| Jun 2020 | - | $44.13M(+22.6%) |
| Mar 2020 | - | $36.01M(-12.5%) |
| Dec 2019 | $41.13M(+14.8%) | $41.13M(+26.0%) |
| Sep 2019 | - | $32.65M(+6.6%) |
| Jun 2019 | - | $30.63M(-11.1%) |
| Mar 2019 | - | $34.46M(-3.8%) |
| Dec 2018 | $35.81M(+21.1%) | $35.81M(-10.9%) |
| Sep 2018 | - | $40.21M(+30.2%) |
| Jun 2018 | - | $30.87M(+11.3%) |
| Mar 2018 | - | $27.75M(-6.2%) |
| Dec 2017 | $29.57M(+8.0%) | $29.57M(+21.3%) |
| Sep 2017 | - | $24.37M(+19.5%) |
| Jun 2017 | - | $20.39M(-20.8%) |
| Mar 2017 | - | $25.76M(-5.9%) |
| Dec 2016 | $27.37M(-18.1%) | $27.37M(-13.6%) |
| Sep 2016 | - | $31.68M(+1.6%) |
| Jun 2016 | - | $31.18M(-4.8%) |
| Mar 2016 | - | $32.74M(-2.0%) |
| Dec 2015 | $33.40M(-12.1%) | $33.40M(-4.3%) |
| Sep 2015 | - | $34.90M(-5.2%) |
| Jun 2015 | - | $36.83M(-2.2%) |
| Mar 2015 | - | $37.65M(-1.0%) |
| Dec 2014 | $38.02M | $38.02M(-1.2%) |
| Sep 2014 | - | $38.48M(-6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $40.94M(-5.8%) |
| Mar 2014 | - | $43.46M(+3.3%) |
| Dec 2013 | $42.06M(+12.5%) | $42.06M(+4.4%) |
| Sep 2013 | - | $40.28M(+2.5%) |
| Jun 2013 | - | $39.32M(+5.9%) |
| Mar 2013 | - | $37.14M(-0.7%) |
| Dec 2012 | $37.39M(+643.9%) | $37.39M(+10.4%) |
| Sep 2012 | - | $33.87M(+482.4%) |
| Jun 2012 | - | $5.82M(+62.9%) |
| Mar 2012 | - | $3.57M(-29.0%) |
| Dec 2011 | $5.03M(+30.2%) | $5.03M(+85.3%) |
| Sep 2011 | - | $2.71M(-29.6%) |
| Jun 2011 | - | $3.86M(+20.7%) |
| Mar 2011 | - | $3.20M(-17.2%) |
| Dec 2010 | $3.86M(+59.6%) | $3.86M(+35.0%) |
| Jun 2010 | - | $2.86M(+33.4%) |
| Mar 2010 | - | $2.14M(-11.4%) |
| Dec 2009 | $2.42M(-15.7%) | $2.42M(+2.6%) |
| Sep 2009 | - | $2.36M(+10.2%) |
| Jun 2009 | - | $2.14M(-34.9%) |
| Mar 2009 | - | $3.29M(+14.6%) |
| Dec 2008 | $2.87M(-4.7%) | $2.87M(-13.0%) |
| Sep 2008 | - | $3.29M(+70.8%) |
| Jun 2008 | - | $1.93M(-17.0%) |
| Mar 2008 | - | $2.32M(-22.8%) |
| Dec 2007 | $3.01M(-15.0%) | $3.01M(+12.2%) |
| Sep 2007 | - | $2.68M(+86.0%) |
| Jun 2007 | - | $1.44M(-35.1%) |
| Mar 2007 | - | $2.22M(-37.3%) |
| Dec 2006 | $3.54M(-0.6%) | $3.54M(-37.5%) |
| Sep 2006 | - | $5.67M(+8.9%) |
| Jun 2006 | - | $5.20M(-0.6%) |
| Mar 2006 | - | $5.23M(+46.9%) |
| Dec 2005 | $3.56M(+95.3%) | $3.56M(+31.9%) |
| Sep 2005 | - | $2.70M(+78.5%) |
| Jun 2005 | - | $1.51M(+20.0%) |
| Mar 2005 | - | $1.26M(-30.9%) |
| Dec 2004 | $1.82M(-95.8%) | $1.82M(+11.6%) |
| Sep 2004 | - | $1.63M(+16.7%) |
| Jun 2004 | - | $1.40M(-96.8%) |
| Mar 2004 | - | $43.77M(+1.2%) |
| Dec 2003 | $43.25M(-1.1%) | $43.25M |
| Dec 2002 | $43.73M(+2221.4%) | - |
| Dec 2001 | $1.88M | - |
FAQ
- What is Corcept Therapeutics Incorporated annual total liabilities?
- What is the all time high annual total liabilities for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual total liabilities year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly total liabilities?
- What is the all time high quarterly total liabilities for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly total liabilities year-on-year change?
What is Corcept Therapeutics Incorporated annual total liabilities?
The current annual total liabilities of CORT is $160.96M
What is the all time high annual total liabilities for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual total liabilities is $160.96M
What is Corcept Therapeutics Incorporated annual total liabilities year-on-year change?
Over the past year, CORT annual total liabilities has changed by +$46.15M (+40.20%)
What is Corcept Therapeutics Incorporated quarterly total liabilities?
The current quarterly total liabilities of CORT is $163.17M
What is the all time high quarterly total liabilities for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly total liabilities is $163.17M
What is Corcept Therapeutics Incorporated quarterly total liabilities year-on-year change?
Over the past year, CORT quarterly total liabilities has changed by +$55.10M (+50.98%)